Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The involvement of the sigma-1 receptor in neurodegeneration and neurorestoration
Karsten Ruscher, Tadeusz Wieloch
Journal of Pharmacological Sciences (2014) Vol. 127, Iss. 1, pp. 30-35
Open Access | Times Cited: 92

Showing 1-25 of 92 citing articles:

The Therapeutic Potentials of Ayahuasca: Possible Effects against Various Diseases of Civilization
Ede Frecska, Petra Bokor, Michael Winkelman
Frontiers in Pharmacology (2016) Vol. 7
Open Access | Times Cited: 211
Pharmacology of dextromethorphan: Relevance to dextromethorphan/quinidine (Nuedexta®) clinical use
Charles P. Taylor, Stephen F. Traynelis, João Siffert, et al.
Pharmacology & Therapeutics (2016) Vol. 164, pp. 170-182
Open Access | Times Cited: 155
Novel mechanisms for DHEA action
Russell A. Prough, Barbara J. Clark, Carolyn M. Klinge
Journal of Molecular Endocrinology (2016) Vol. 56, Iss. 3, pp. R139-R155
Open Access | Times Cited: 144
The Role of Sigma-1 Receptor, an Intracellular Chaperone in Neurodegenerative Diseases
Botond Penke, Lívia Fülöp, Mária Szűcs, et al.
Current Neuropharmacology (2017) Vol. 16, Iss. 1
Open Access | Times Cited: 110
Roles of sigma-1 receptors on mitochondrial functions relevant to neurodegenerative diseases
Tzu-Yu Weng, Shang‐Yi Tsai, Tsung‐Ping Su
Journal of Biomedical Science (2017) Vol. 24, Iss. 1
Open Access | Times Cited: 103
Loss-of-function mutations in theSIGMAR1gene cause distal hereditary motor neuropathy by impairing ER-mitochondria tethering and Ca2+signalling
Elisa Gregianin, Giorgia Pallafacchina, Sofia Zanin, et al.
Human Molecular Genetics (2016) Vol. 25, Iss. 17, pp. 3741-3753
Open Access | Times Cited: 93
Cancer nanotheranostics: A review of the role of conjugated ligands for overexpressed receptors
Lydia Ramzy, Maha Nasr, Abdelkader A. Metwally, et al.
European Journal of Pharmaceutical Sciences (2017) Vol. 104, pp. 273-292
Closed Access | Times Cited: 92
Dark Classics in Chemical Neuroscience: N,N-Dimethyltryptamine (DMT)
Lindsay P. Cameron, David E. Olson
ACS Chemical Neuroscience (2018) Vol. 9, Iss. 10, pp. 2344-2357
Closed Access | Times Cited: 91
Toxicokinetics and Toxicodynamics of Ayahuasca Alkaloids N,N-Dimethyltryptamine (DMT), Harmine, Harmaline and Tetrahydroharmine: Clinical and Forensic Impact
Andreia Machado Brito-da-Costa, Diana Dias da Silva, Nelson G. M. Gomes, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 11, pp. 334-334
Open Access | Times Cited: 86
Methamphetamine-Induced Neuronal Damage: Neurotoxicity and Neuroinflammation
Buyun Kim, Jangmi Yun, Byoungduck Park
Biomolecules & Therapeutics (2020) Vol. 28, Iss. 5, pp. 381-388
Open Access | Times Cited: 81
New therapeutics beyond amyloid-β and tau for the treatment of Alzheimer’s disease
Feng Zhang, Rujia Zhong, Cheng Cheng, et al.
Acta Pharmacologica Sinica (2020) Vol. 42, Iss. 9, pp. 1382-1389
Open Access | Times Cited: 72
Long COVID, neuropsychiatric disorders, psychotropics, present and future
Siu Wa Tang, Brian E. Leonard, Daiga M. Helmeste
Acta Neuropsychiatrica (2022) Vol. 34, Iss. 3, pp. 109-126
Open Access | Times Cited: 46
Recent Advances in Drug Therapy for Parkinson's Disease
Hidetomo Murakami, Tomotaka Shiraishi, Tadashi Umehara, et al.
Internal Medicine (2022) Vol. 62, Iss. 1, pp. 33-42
Open Access | Times Cited: 38
Evolving therapeutic interventions for the management and treatment of Alzheimer’s disease
Faizan Ahmad, Anik Karan, Rashi Sharma, et al.
Ageing Research Reviews (2024) Vol. 95, pp. 102229-102229
Closed Access | Times Cited: 15
Activation of the molecular chaperone, sigma 1 receptor, preserves cone function in a murine model of inherited retinal degeneration
Jing Wang, Alan Saul, Penny Roon, et al.
Proceedings of the National Academy of Sciences (2016) Vol. 113, Iss. 26
Open Access | Times Cited: 71
Sigma-1 Receptor-Modulated Neuroinflammation in Neurological Diseases
Jia Jia, Jian Cheng, Cheng Wang, et al.
Frontiers in Cellular Neuroscience (2018) Vol. 12
Open Access | Times Cited: 70
A precision medicine framework using artificial intelligence for the identification and confirmation of genomic biomarkers of response to an Alzheimer's disease therapy: Analysis of the blarcamesine (ANAVEX2‐73) Phase 2a clinical study
Harald Hampel, Coralie Williams, Adrien Etcheto, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 65
Small Molecules Selectively Targeting Sigma-1 Receptor for the Treatment of Neurological Diseases
Na Ye, Wangzhi Qin, Sheng Tian, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 24, pp. 15187-15217
Closed Access | Times Cited: 63
N,N-dimethyltryptamine reduces infarct size and improves functional recovery following transient focal brain ischemia in rats
Sándor Nardai, János Marcell László, Attila Szabó, et al.
Experimental Neurology (2020) Vol. 327, pp. 113245-113245
Closed Access | Times Cited: 59
From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders
Urszula Kozłowska, Charles D. Nichols, Kalina Wiatr, et al.
Journal of Neurochemistry (2021) Vol. 162, Iss. 1, pp. 89-108
Open Access | Times Cited: 53
Ayahuasca's therapeutic potential: What we know – and what not
Lucas Oliveira Maia, Dimitri Daldegan‐Bueno, Isabel Wießner, et al.
European Neuropsychopharmacology (2022) Vol. 66, pp. 45-61
Closed Access | Times Cited: 28
Imaging diagnosis in peripheral nerve injury
Yanzhao Dong, Ahmad Alhaskawi, Haiying Zhou, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 21
Golgi fragmentation in amyotrophic lateral sclerosis, an overview of possible triggers and consequences
Vinod Sundaramoorthy, Jessica M. Sultana, Julie D. Atkin
Frontiers in Neuroscience (2015) Vol. 9
Open Access | Times Cited: 60
Methamphetamine Induces Dopamine Release in the Nucleus Accumbens Through a Sigma Receptor-Mediated Pathway
David M. Hedges, J. Daniel Obray, Jordan T. Yorgason, et al.
Neuropsychopharmacology (2017) Vol. 43, Iss. 6, pp. 1405-1414
Open Access | Times Cited: 60
Neuroprotection and neurorestoration as experimental therapeutics for Parkinson's disease
Veronica Francardo, Yvonne Schmitz, David Sulzer, et al.
Experimental Neurology (2017) Vol. 298, pp. 137-147
Closed Access | Times Cited: 55
Page 1 - Next Page

Scroll to top